Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pirfeza 200mg Tablet

Prescription Icon
Prescription Required

Marketer

Uniza Healthcare LLP

Salt Composition

Pirfenidone (200mg)

Overview Pirfeza 200mg Tablet

Nintedanib 200mg tablets, a prescription medication, are indicated for idiopathic pulmonary fibrosis. This treatment mitigates lung inflammation and fibrosis, improving respiratory function. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage frequency is determined by your physician based on individual needs and response. Continue treatment as directed. Common adverse effects include sleep disturbances, headache, vertigo, indigestion, nausea, loose stools, and sun sensitivity. To minimize dizziness, refrain from driving or activities requiring focused attention. Weight loss is possible; regular monitoring is advised, and consult your physician if this occurs. Liver function tests may be conducted during treatment. Disclose any pre-existing liver or kidney conditions, and all other medications currently being used, as potential interactions can affect efficacy. Due to increased sun sensitivity, protective clothing and sunscreen are recommended during sun exposure. Inform your doctor if you are pregnant or lactating.

Uses of Pirfeza 200mg Tablet

Managing idiopathic pulmonary fibrosis

Major Benefits of Pirfeza 200mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Pirfeza 200mg Tablet with a meal.

Common Side effects of Pirfeza 200mg Tablet:

  • Insomnia (difficulty in sleeping)
  • Headache
  • Dizziness
  • Tiredness
  • Sinus inflammation
  • Loss of appetite
  • Upper respiratory tract infection
  • Weight loss
  • Nausea
  • Indigestion
  • Diarrhea
  • Photosensitivity

How to use Pirfeza 200mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 200mg Pirfeza tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Pirfeza 200mg Tablet works:

Pirfenidone 200mg tablets are an antifibrotic agent. Their mechanism involves inhibiting a specific endogenous compound implicated in fibrotic processes. This consequently diminishes pulmonary scarring and inflammation, facilitating improved respiration.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Pirfeza 200mg Tablet may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Pirfeza 200mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Pirfeza 200mg Tablet with breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a 200mg Pirfeza tablet can cause drowsiness, blurred vision, dizziness, and reduced alertness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should use Pirfeza 200mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Pirfeza 200mg tablets are unsuitable for individuals with severe kidney disease or those undergoing dialysis.

LiverLiverCAUTION

Patients with liver impairment should use Pirfeza 200mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Pirfeza 200mg tablets are contraindicated in those with severe hepatic dysfunction.

What if you forget to take Pirfeza 200mg Tablet :

NA

Facts to Know About Pirfeza 200mg Tablet

LabelValue
Chemical Type Pyridone Derivative
Developing Habits No.
Treatment Category Breathing
Action Class Pulmonary fibrosis of unknown cause

FAQs on Pirfeza 200mg Tablet

Prior to beginning Pirfeza 200mg Tablet treatment, your doctor will assess your liver function. This assessment will be repeated monthly for six months, then every three months thereafter. Your lung function will also be monitored regularly to track your response to the medication.
Protecting your irreplaceable lung function is crucial to managing this disease. Therefore, your doctor's prescription of Pirfeza 200mg Tablet should be followed diligently to help maintain your current lung capacity.
Pirfeza 200mg Tablet may cause sun sensitivity, nausea, fatigue, diarrhea, indigestion, appetite loss, and headache. Other possible side effects include upper respiratory or urinary tract infections, weight loss, sleep disturbances, dizziness, altered taste, hot flashes, shortness of breath, and cough. Gastrointestinal issues like acid reflux, vomiting, bloating, abdominal pain, heartburn, and constipation may also occur. Skin reactions such as itching, redness, dryness, and rash are possible, along with muscle pain, joint pain, weakness, chest pain, and sunburn. Elevated liver enzyme levels may be detected in blood tests.
Pirfeza 200mg tablets are not steroids; they're pyridines used to treat idiopathic pulmonary fibrosis (IPF) in adults. IPF causes lung tissue scarring and swelling, hindering breathing. Pirfeza helps alleviate these effects, improving breathing.
You and your doctor should determine together if Pirfeza 200mg Tablet is appropriate for you. Your doctor will prescribe it only after evaluating your health. Continued use depends on your response to and tolerance of the medication.
Idiopathic pulmonary fibrosis progresses unpredictably. Always consult your doctor before stopping Pirfeza 200mg Tablet; continued use may help slow disease progression.
Minimize sun exposure while using Pirfeza 200mg Tablets. Daily sunscreen and protective clothing (covering arms, legs, and head) are recommended. Avoid smoking, as it can reduce Pirfeza's effectiveness.
While the average survival time for pulmonary fibrosis patients is two to three years, many individuals live significantly longer. Reduced survival is often associated with older age, smoking, and low body mass index. Additionally, more extensive disease (radiologically and functionally), and the presence of other lung problems, can negatively impact lifespan.
Pirfeza 200mg Tablet
197
MRP 228
13% off